Delaware | 1-12626 | 62-1539359 | ||||||||||||
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
200 South Wilcox Drive | ||||||||
Kingsport | Tennessee | 37662 | ||||||
(Address of Principal Executive Offices) | (Zip Code) |
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||||||||
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||||||||
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||||||||
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Common Stock, par value $0.01 per share | EMN | New York Stock Exchange | ||||||||||||
1.50% Notes Due 2023 | EMN23 | New York Stock Exchange | ||||||||||||
1.875% Notes Due 2026 | EMN26 | New York Stock Exchange |
EASTMAN CHEMICAL COMPANY - EMN |
EASTMAN CHEMICAL COMPANY - EMN |
Eastman Chemical Company | ||||||||
By: | /s/ Michelle R. Stewart | |||||||
Michelle R. Stewart | ||||||||
Vice President, Corporate Controller and Chief Accounting Officer | ||||||||
Date: April 27, 2023 |
(In millions, except per share amounts; unaudited) | 1Q2023 | 1Q2022 | ||||||
Sales revenue | $2,412 | $2,714 | ||||||
Earnings before interest and taxes ("EBIT") | 246 | 333 | ||||||
Adjusted EBIT* | 283 | 366 | ||||||
Earnings per diluted share | 1.12 | 1.80 | ||||||
Adjusted earnings per diluted share* | 1.63 | 2.06 | ||||||
Net cash (used in) provided by operating activities | (2) | 17 | ||||||
Item | Page | |||||||
First Quarter | |||||||||||
(Dollars in millions, except per share amounts; unaudited) | 2023 | 2022 | |||||||||
Sales | $ | 2,412 | $ | 2,714 | |||||||
Cost of sales (1)(2) | 1,883 | 2,164 | |||||||||
Gross profit | 529 | 550 | |||||||||
Selling, general and administrative expenses | 191 | 196 | |||||||||
Research and development expenses | 62 | 65 | |||||||||
Asset impairments and restructuring charges, net | 22 | 2 | |||||||||
Other components of post-employment (benefit) cost, net | (3) | (31) | |||||||||
Other (income) charges, net | 11 | (12) | |||||||||
Gain on divested business | — | (3) | |||||||||
Earnings before interest and taxes | 246 | 333 | |||||||||
Net interest expense | 52 | 46 | |||||||||
Earnings before income taxes | 194 | 287 | |||||||||
Provision for income taxes | 60 | 51 | |||||||||
Net earnings | 134 | 236 | |||||||||
Less: Net earnings attributable to noncontrolling interest | — | 1 | |||||||||
Net earnings attributable to Eastman | $ | 134 | $ | 235 | |||||||
Basic earnings per share attributable to Eastman | $ | 1.13 | $ | 1.82 | |||||||
Diluted earnings per share attributable to Eastman | $ | 1.12 | $ | 1.80 | |||||||
Shares (in millions) outstanding at end of period | 119.2 | 128.9 | |||||||||
Shares (in millions) used for earnings per share calculation | |||||||||||
Basic | 118.9 | 129.0 | |||||||||
Diluted | 119.7 | 130.7 |
First Quarter | |||||||||||
(Dollars in millions, unaudited) | 2023 | 2022 | |||||||||
Sales by Segment | |||||||||||
Advanced Materials | $ | 742 | $ | 737 | |||||||
Additives & Functional Products (1) | 777 | 889 | |||||||||
Chemical Intermediates (1) | 589 | 715 | |||||||||
Fibers | 303 | 213 | |||||||||
Total Sales by Segment | 2,411 | 2,554 | |||||||||
Other (2) | 1 | 160 | |||||||||
Total Eastman Chemical Company | $ | 2,412 | $ | 2,714 |
Fourth Quarter | ||||||||
(Dollars in millions, unaudited) | 2022 | |||||||
Sales by Segment | ||||||||
Advanced Materials | $ | 736 | ||||||
Additives & Functional Products (1) | 756 | |||||||
Chemical Intermediates (1) | 564 | |||||||
Fibers | 317 | |||||||
Total Eastman Chemical Company | $ | 2,373 |
First Quarter 2023 Compared to First Quarter 2022 | |||||||||||||||||
Change in Sales Revenue Due To | |||||||||||||||||
(Unaudited) | Revenue % Change | Volume / Product Mix Effect | Price Effect | Exchange Rate Effect | Divested Business Effect(1) | ||||||||||||
Advanced Materials | 1 | % | (6) | % | 10 | % | (3) | % | — | % | |||||||
Additives & Functional Products | (13) | % | (15) | % | 4 | % | (2) | % | — | % | |||||||
Chemical Intermediates | (18) | % | (12) | % | (5) | % | (1) | % | — | % | |||||||
Fibers | 42 | % | 3 | % | 40 | % | (1) | % | — | % | |||||||
Other | (99) | % | 1 | % | — | % | — | % | (100) | % | |||||||
Total Eastman Chemical Company | (11) | % | (9) | % | 6 | % | (2) | % | (6) | % | |||||||
First Quarter 2023 Compared to Fourth Quarter 2022 | ||||||||||||||
Change in Sales Revenue Due To | ||||||||||||||
(Unaudited) | Revenue % Change | Volume / Product Mix Effect | Price Effect | Exchange Rate Effect | ||||||||||
Advanced Materials | 1 | % | (1) | % | 1 | % | 1 | % | ||||||
Additives & Functional Products | 3 | % | 4 | % | (3) | % | 2 | % | ||||||
Chemical Intermediates | 4 | % | 12 | % | (9) | % | 1 | % | ||||||
Fibers | (4) | % | (18) | % | 14 | % | — | % | ||||||
Total Eastman Chemical Company | 2 | % | 2 | % | (1) | % | 1 | % |
First Quarter | |||||||||||
(Dollars in millions, unaudited) | 2023 | 2022 | |||||||||
Sales by Customer Location | |||||||||||
United States and Canada | $ | 1,065 | $ | 1,198 | |||||||
Europe, Middle East, and Africa | 709 | 745 | |||||||||
Asia Pacific | 521 | 612 | |||||||||
Latin America | 117 | 159 | |||||||||
Total Eastman Chemical Company | $ | 2,412 | $ | 2,714 | |||||||
First Quarter | ||||||||||||||
(Dollars in millions, unaudited) | 2023 | 2022 | ||||||||||||
Advanced Materials | ||||||||||||||
Earnings before interest and taxes | $ | 86 | $ | 61 | ||||||||||
Asset impairments and restructuring charges, net | — | 1 | ||||||||||||
Excluding non-core item | 86 | 62 | ||||||||||||
Additives & Functional Products | ||||||||||||||
Earnings before interest and taxes | 124 | 167 | ||||||||||||
Chemical Intermediates | ||||||||||||||
Earnings before interest and taxes | 42 | 112 | ||||||||||||
Asset impairments and restructuring charges, net | — | 1 | ||||||||||||
Excluding non-core item | 42 | 113 | ||||||||||||
Fibers | ||||||||||||||
Earnings before interest and taxes | 65 | 24 | ||||||||||||
Asset impairments and restructuring charges, net (2) | 6 | — | ||||||||||||
Accelerated depreciation (2) | 23 | — | ||||||||||||
Excluding non-core items | 94 | 24 | ||||||||||||
Other | ||||||||||||||
Loss before interest and taxes | (71) | (31) | ||||||||||||
Asset impairments and restructuring charges, net (3) | 16 | — | ||||||||||||
Net steam line incident costs (insurance proceeds) (4) | (8) | 25 | ||||||||||||
Transaction costs, net of gain on divested business | — | 6 | ||||||||||||
Excluding non-core and unusual items | (63) | — | ||||||||||||
Total Eastman Chemical Company | ||||||||||||||
Earnings before interest and taxes | 246 | 333 | ||||||||||||
Asset impairments and restructuring charges, net | 22 | 2 | ||||||||||||
Net steam line incident costs (insurance proceeds) | (8) | 25 | ||||||||||||
Transaction costs, net of gain on divested business | — | 6 | ||||||||||||
Accelerated depreciation | 23 | — | ||||||||||||
Total earnings before interest and taxes excluding non-core and unusual items | $ | 283 | $ | 366 |
Company Non-GAAP Earnings Before Interest and Taxes Reconciliations by Line Items | ||||||||||||||
Earnings before interest and taxes | $ | 246 | $ | 333 | ||||||||||
Costs of sales | 15 | 25 | ||||||||||||
Selling, general and administrative expenses | — | 9 | ||||||||||||
Asset impairments and restructuring charges, net | 22 | 2 | ||||||||||||
Gain on divested business | — | (3) | ||||||||||||
Total earnings before interest and taxes excluding non-core and unusual items | $ | 283 | $ | 366 |
Fourth Quarter | ||||||||
(Dollars in millions, unaudited) | 2022 | |||||||
Advanced Materials | ||||||||
Earnings before interest and taxes | $ | 43 | ||||||
Additives & Functional Products | ||||||||
Earnings before interest and taxes | 76 | |||||||
Chemical Intermediates | ||||||||
Earnings before interest and taxes | 24 | |||||||
Fibers | ||||||||
Earnings before interest and taxes | 49 | |||||||
Asset impairments and restructuring charges, net | 9 | |||||||
Excluding non-core item | 58 | |||||||
Other | ||||||||
Loss before interest and taxes | (116) | |||||||
Mark-to-market pension and other postretirement benefit plans loss, net | 22 | |||||||
Asset impairments and restructuring charges, net | 20 | |||||||
Net steam line incident costs (insurance proceeds) | (3) | |||||||
Loss on divested businesses and related transaction costs | 53 | |||||||
Adjustments to contingent considerations | (6) | |||||||
Excluding non-core and unusual items | (30) | |||||||
Total Eastman Chemical Company | ||||||||
Earnings before interest and taxes | 76 | |||||||
Mark-to-market pension and other postretirement benefit plans loss, net | 22 | |||||||
Asset impairments and restructuring charges, net | 29 | |||||||
Net steam line incident costs (insurance proceeds) | (3) | |||||||
Loss on divested businesses and related transaction costs | 53 | |||||||
Adjustments to contingent considerations | (6) | |||||||
Total earnings before interest and taxes excluding non-core and unusual items | $ | 171 | ||||||
Company Non-GAAP Earnings Before Interest and Taxes Reconciliations by Line Items | ||||||||
Earnings before interest and taxes | $ | 76 | ||||||
Costs of sales | (3) | |||||||
Selling, general and administrative expenses | 3 | |||||||
Asset impairments and restructuring charges, net | 29 | |||||||
Other components of post-employment (benefit) cost, net | 22 | |||||||
Other (income) charges, net | (6) | |||||||
Net (gain) loss on divested businesses | 50 | |||||||
Total earnings before interest and taxes excluding non-core and unusual items | $ | 171 |
First Quarter | |||||||||||||||||
(Dollars in millions, unaudited) | 2023 | 2022 | |||||||||||||||
Adjusted EBIT | Adjusted EBIT Margin | Adjusted EBIT | Adjusted EBIT Margin | ||||||||||||||
Advanced Materials | $ | 86 | 11.6 | % | $ | 62 | 8.4 | % | |||||||||
Additives & Functional Products (3) | 124 | 16.0 | % | 167 | 18.8 | % | |||||||||||
Chemical Intermediates (3) | 42 | 7.1 | % | 113 | 15.8 | % | |||||||||||
Fibers | 94 | 31.0 | % | 24 | 11.3 | % | |||||||||||
Total segment EBIT excluding non-core and unusual items | 346 | 14.4 | % | 366 | 14.3 | % | |||||||||||
Other | (63) | — | |||||||||||||||
Total EBIT excluding non-core and unusual items | $ | 283 | 11.7 | % | $ | 366 | 13.5 | % |
Fourth Quarter | ||||||||
(Dollars in millions, unaudited) | 2022 | |||||||
Adjusted EBIT | Adjusted EBIT Margin | |||||||
Advanced Materials | $ | 43 | 5.8 | % | ||||
Additives & Functional Products (3) | 76 | 10.1 | % | |||||
Chemical Intermediates (3) | 24 | 4.3 | % | |||||
Fibers | 58 | 18.3 | % | |||||
Total segment EBIT excluding non-core and unusual items | 201 | 8.5 | % | |||||
Other | (30) | |||||||
Total EBIT excluding non-core and unusual items | $ | 171 | 7.2 | % | ||||
First Quarter 2023 | ||||||||||||||||||||||||||||||||||||||
Earnings Before Interest and Taxes | Earnings Before Income Taxes | Provision for Income Taxes | Effective Income Tax Rate | Net Earnings Attributable to Eastman | ||||||||||||||||||||||||||||||||||
(Dollars in millions, except per share amounts, unaudited) | After Tax | Per Diluted Share | ||||||||||||||||||||||||||||||||||||
As reported (GAAP) | $ | 246 | $ | 194 | $ | 60 | 31 | % | $ | 134 | $ | 1.12 | ||||||||||||||||||||||||||
Non-Core and Unusual Items: (1) | ||||||||||||||||||||||||||||||||||||||
Asset impairments and restructuring charges, net | 22 | 22 | 4 | 18 | 0.14 | |||||||||||||||||||||||||||||||||
Accelerated depreciation | 23 | 23 | 3 | 20 | 0.17 | |||||||||||||||||||||||||||||||||
Steam line incident insurance proceeds, net of costs | (8) | (8) | (2) | (6) | (0.05) | |||||||||||||||||||||||||||||||||
Adjustment from tax law changes (2) | — | — | (23) | 23 | 0.19 | |||||||||||||||||||||||||||||||||
Interim adjustment to tax provision (3) | — | — | (6) | 6 | 0.06 | |||||||||||||||||||||||||||||||||
Non-GAAP (Excluding non-core and unusual items and with adjusted provision for income taxes) | $ | 283 | $ | 231 | $ | 36 | 16 | % | $ | 195 | $ | 1.63 |
First Quarter 2022 | ||||||||||||||||||||||||||||||||||||||
Earnings Before Interest and Taxes | Earnings Before Income Taxes | Provision for Income Taxes | Effective Income Tax Rate | Net Earnings Attributable to Eastman | ||||||||||||||||||||||||||||||||||
(Dollars in millions, except per share amounts, unaudited) | After Tax | Per Diluted Share | ||||||||||||||||||||||||||||||||||||
As reported (GAAP) | $ | 333 | $ | 287 | $ | 51 | 18 | % | $ | 235 | $ | 1.80 | ||||||||||||||||||||||||||
Non-Core and Unusual Items: (1) | ||||||||||||||||||||||||||||||||||||||
Asset impairments and restructuring charges, net | 2 | 2 | 1 | 1 | — | |||||||||||||||||||||||||||||||||
Transaction costs, net of gain on divested business | 6 | 6 | (2) | 8 | 0.07 | |||||||||||||||||||||||||||||||||
Steam line incident costs, net of insurance proceeds | 25 | 25 | 6 | 19 | 0.14 | |||||||||||||||||||||||||||||||||
Interim adjustment to tax provision (3) | — | — | (6) | 6 | 0.05 | |||||||||||||||||||||||||||||||||
Non-GAAP (Excluding non-core and unusual items and with adjusted provision for income taxes) | $ | 366 | $ | 320 | $ | 50 | 16 | % | $ | 269 | $ | 2.06 |
Fourth Quarter 2022 | ||||||||||||||||||||||||||||||||||||||
Earnings Before Interest and Taxes | Earnings Before Income Taxes | Provision for Income Taxes | Effective Income Tax Rate | Net Earnings Attributable to Eastman | ||||||||||||||||||||||||||||||||||
(Dollars in millions, except per share amounts, unaudited) | After Tax | Per Diluted Share | ||||||||||||||||||||||||||||||||||||
As reported (GAAP) | $ | 76 | $ | 28 | $ | 26 | 95 | % | $ | 1 | $ | 0.01 | ||||||||||||||||||||||||||
Non-Core and Unusual Items: (1) | ||||||||||||||||||||||||||||||||||||||
Asset impairments and restructuring charges, net | 29 | 29 | (1) | 30 | 0.26 | |||||||||||||||||||||||||||||||||
Loss on divested businesses and related transaction costs | 53 | 53 | 3 | 50 | 0.40 | |||||||||||||||||||||||||||||||||
Steam line incident insurance proceeds, net of costs | (3) | (3) | — | (3) | (0.01) | |||||||||||||||||||||||||||||||||
Mark-to-market pension and other postretirement benefit plans loss, net | 22 | 22 | 5 | 17 | 0.14 | |||||||||||||||||||||||||||||||||
Adjustments to contingent considerations | (6) | (6) | (2) | (4) | (0.04) | |||||||||||||||||||||||||||||||||
Interim adjustment to tax provision (2) | — | — | (16) | 16 | 0.13 | |||||||||||||||||||||||||||||||||
Non-GAAP (Excluding non-core and unusual items and with adjusted provision for income taxes) | $ | 171 | $ | 123 | $ | 15 | 13 | % | $ | 107 | $ | 0.89 |
First Three Months (1) | |||||||||||
2023 | 2022 | ||||||||||
Effective tax rate | 31 | % | 18 | % | |||||||
Discrete tax items (2) | — | % | 1 | % | |||||||
Tax impact of current year non-core and unusual items (3) | (8) | % | 1 | % | |||||||
Changes in tax contingencies and valuation allowances | (1) | % | (1) | % | |||||||
Forecasted full year impact of expected tax events | (6) | % | (3) | % | |||||||
Forecasted full year adjusted effective tax rate | 16 | % | 16 | % |
First Three Months | |||||||||||
(Dollars in millions, unaudited) | 2023 | 2022 | |||||||||
Operating activities | |||||||||||
Net earnings | $ | 134 | $ | 236 | |||||||
Adjustments to reconcile net earnings to net cash provided by operating activities: | |||||||||||
Depreciation and amortization | 141 | 121 | |||||||||
Gain on divested business | — | (3) | |||||||||
Benefit from deferred income taxes | (7) | (24) | |||||||||
Changes in operating assets and liabilities, net of effect of acquisitions and divestitures: | |||||||||||
(Increase) decrease in trade receivables | (91) | (127) | |||||||||
(Increase) decrease in inventories | (44) | (184) | |||||||||
Increase (decrease) in trade payables | (132) | 152 | |||||||||
Pension and other postretirement contributions (in excess of) less than expenses | (19) | (43) | |||||||||
Variable compensation payments (in excess of) less than expenses | (16) | (168) | |||||||||
Other items, net | 32 | 57 | |||||||||
Net cash (used in) provided by operating activities | (2) | 17 | |||||||||
Investing activities | |||||||||||
Additions to properties and equipment | (174) | (112) | |||||||||
Proceeds from sale of businesses | 16 | — | |||||||||
Acquisition, net of cash acquired | (73) | — | |||||||||
Additions to capitalized software | (2) | (3) | |||||||||
Other items, net | (19) | (2) | |||||||||
Net cash used in investing activities | (252) | (117) | |||||||||
Financing activities | |||||||||||
Net increase (decrease) in commercial paper and other borrowings | (326) | 236 | |||||||||
Proceeds from borrowings | 796 | — | |||||||||
Dividends paid to stockholders | (94) | (98) | |||||||||
Proceeds from stock option exercises and other items, net | (19) | (9) | |||||||||
Net cash provided by financing activities | 357 | 129 | |||||||||
Effect of exchange rate changes on cash and cash equivalents | 3 | (1) | |||||||||
Net change in cash and cash equivalents | 106 | 28 | |||||||||
Cash and cash equivalents at beginning of period | 493 | 459 | |||||||||
Cash and cash equivalents at end of period | $ | 599 | $ | 487 |
March 31, | December 31, | |||||||||||||
(Dollars in millions, unaudited) | 2023 | 2022 | ||||||||||||
Total borrowings | $ | 5,650 | $ | 5,151 | ||||||||||
Less: Cash and cash equivalents | 599 | 493 | ||||||||||||
Net debt (1) | $ | 5,051 | $ | 4,658 |
2022 | ||||||||||||||||||||||||||||||||
(Dollars in millions) | First Quarter | Second Quarter | Third Quarter | Fourth Quarter | Full Year | |||||||||||||||||||||||||||
Additives & Functional Products | ||||||||||||||||||||||||||||||||
Sales | $ | 889 | $ | 924 | $ | 906 | $ | 756 | $ | 3,475 | ||||||||||||||||||||||
Earnings (loss) before interest and taxes ("EBIT") | 167 | 160 | 143 | 76 | 546 | |||||||||||||||||||||||||||
Depreciation and amortization | 142 | |||||||||||||||||||||||||||||||
Chemical Intermediates | ||||||||||||||||||||||||||||||||
Sales | $ | 715 | $ | 772 | $ | 665 | $ | 564 | $ | 2,716 | ||||||||||||||||||||||
EBIT | 112 | 142 | 68 | 24 | 346 | |||||||||||||||||||||||||||
Asset impairments and restructuring charges, net | 1 | 1 | 1 | 1 | 1 | 1 | — | 3 | 1 | |||||||||||||||||||||||
EBIT excluding non-core item | 113 | 143 | 69 | 24 | 349 | |||||||||||||||||||||||||||
Depreciation and amortization | 104 |
2021 | ||||||||||||||||||||||||||||||||
(Dollars in millions) | First Quarter | Second Quarter | Third Quarter | Fourth Quarter | Full Year | |||||||||||||||||||||||||||
Additives & Functional Products | ||||||||||||||||||||||||||||||||
Sales | $ | 672 | $ | 722 | $ | 775 | $ | 780 | $ | 2,949 | ||||||||||||||||||||||
EBIT | 124 | 115 | 130 | 112 | 481 | |||||||||||||||||||||||||||
Asset impairments and restructuring charges, net | — | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 4 | 1 | ||||||||||||||||||||||
EBIT excluding non-core items | 124 | 117 | 131 | 113 | 485 | |||||||||||||||||||||||||||
Depreciation and amortization | 141 | |||||||||||||||||||||||||||||||
Chemical Intermediates | ||||||||||||||||||||||||||||||||
Sales | $ | 542 | $ | 669 | $ | 685 | $ | 712 | $ | 2,608 | ||||||||||||||||||||||
EBIT | 52 | 131 | 130 | 99 | 412 | |||||||||||||||||||||||||||
Asset impairments and restructuring charges, net | 4 | 2 | 7 | 2 | 2 | 2 | 3 | 2 | 16 | 2 | ||||||||||||||||||||||
EBIT excluding non-core items | 56 | 138 | 132 | 102 | 428 | |||||||||||||||||||||||||||
Depreciation and amortization | 102 |
2020 | ||||||||||||||||||||||||||||||||
(Dollars in millions) | First Quarter | Second Quarter | Third Quarter | Fourth Quarter | Full Year | |||||||||||||||||||||||||||
Additives & Functional Products | ||||||||||||||||||||||||||||||||
Sales | $ | 636 | $ | 567 | $ | 551 | $ | 588 | $ | 2,342 | ||||||||||||||||||||||
EBIT | 135 | 104 | 95 | 106 | 440 | |||||||||||||||||||||||||||
Asset impairments and restructuring charges, net | 2 | 1 | — | 1 | 2 | — | 3 | 1,2 | ||||||||||||||||||||||||
EBIT excluding non-core items | 137 | 104 | 96 | 106 | 443 | |||||||||||||||||||||||||||
Depreciation and amortization | 132 | |||||||||||||||||||||||||||||||
Chemical Intermediates | ||||||||||||||||||||||||||||||||
Sales | $ | 516 | $ | 392 | $ | 464 | $ | 471 | $ | 1,843 | ||||||||||||||||||||||
EBIT | 59 | (2) | 25 | 26 | 108 | |||||||||||||||||||||||||||
Asset impairments and restructuring charges, net | 1 | 3 | 2 | 3 | 1 | 3 | 1 | 3 | 5 | 3 | ||||||||||||||||||||||
EBIT excluding non-core item | 60 | — | 26 | 27 | 113 | |||||||||||||||||||||||||||
Depreciation and amortization | 101 |
2019 | ||||||||||||||||||||||||||||||||
(Dollars in millions) | First Quarter | Second Quarter | Third Quarter | Fourth Quarter | Full Year | |||||||||||||||||||||||||||
Additives & Functional Products | ||||||||||||||||||||||||||||||||
Sales | $ | 650 | $ | 618 | $ | 619 | $ | 568 | $ | 2,455 | ||||||||||||||||||||||
EBIT | 119 | 122 | 118 | 42 | 401 | |||||||||||||||||||||||||||
Asset impairments and restructuring charges, net | 4 | 1 | — | — | 50 | 2 | 54 | 1,2 | ||||||||||||||||||||||||
EBIT excluding non-core items | 123 | 122 | 118 | 92 | 455 | |||||||||||||||||||||||||||
Depreciation and amortization | 176 | |||||||||||||||||||||||||||||||
Chemical Intermediates | ||||||||||||||||||||||||||||||||
Sales | $ | 592 | $ | 572 | $ | 533 | $ | 534 | $ | 2,231 | ||||||||||||||||||||||
EBIT | 66 | 50 | 25 | (4) | 137 | |||||||||||||||||||||||||||
Asset impairments and restructuring charges, net | — | — | — | 22 | 3 | 22 | 3 | |||||||||||||||||||||||||
EBIT excluding non-core item | 66 | 50 | 25 | 18 | 159 | |||||||||||||||||||||||||||
Depreciation and amortization | 102 |